Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myelofibrosis
Pharma
Can mixed results gain an expansion for Karyopharm's Xpovio?
Karyopharm has provided mixed results from a phase 3 trial testing Xpovio in combination with Incyte's Jakafi in patients with myelofibrosis.
Kevin Dunleavy
Mar 24, 2026 11:56am
Sanofi inks $1.5B deal for Sino Biopharm's novel asset
Mar 4, 2026 3:00am
Bristol Myers' clinical woes deepen with failed Reblozyl ph. 3
Jul 18, 2025 11:28am
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
Incyte turns to AI to illustrate the unseen symptoms of MPNs
Mar 5, 2024 12:00pm
GSK, ex-"Queer Eye" star launch myelofibrosis education campaign
Nov 13, 2023 9:50am
